Arch Biopartners(TSE:ARCH)
CA$1.02+0.10 (+10.87%)
TSE:ARCH
Arch Biopartners stock drug pipeline
CA$1.02
At close:+0.10 (+10.87%)
Want to see TSE:ARCH full AI Analyst Report?
Arch Biopartners (ARCH) Drug Pipeline
51 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Lsalt Peptide | Acute Kidney Injury, Cardiac Surgery | Phase II | Recruiting | LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery | May 18, 2023 | ― |
| Lsalt Peptide | Covid, Acute Kidney Injury, Acute Respiratory Distress Syndrome, Sars-Cov2, Severe Acute Respiratory Syndrome | Phase II | Completed | LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) | May 12, 2020 | ― |
| 0.9% Saline, Lsalt Peptide | None - Study Is To Determine Safety In Healthy Participants | earlyPhase1 | Completed | A Phase I Study to Evaluate LSALT Peptide | Dec 09, 2018 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Lsalt Peptide | Phase II | Acute Kidney Injury, Cardiac Surgery | Recruiting | LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery | May 18, 2023 | ― |
| Lsalt Peptide | Phase II | Covid, Acute Kidney Injury, Acute Respiratory Distress Syndrome, Sars-Cov2, Severe Acute Respiratory Syndrome | Completed | LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19) | May 12, 2020 | ― |
| 0.9% Saline, Lsalt Peptide | earlyPhase1 | None - Study Is To Determine Safety In Healthy Participants | Completed | A Phase I Study to Evaluate LSALT Peptide | Dec 09, 2018 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Arch Biopartners (TSE:ARCH) have in its pipeline
Arch Biopartners TSE:ARCH is currently developing the following drugs: Lsalt Peptide, 0.9% Saline, Lsalt Peptide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
